130. Kongress der Deutschen Gesellschaft für Innere Medizin
zur Liste
Dr. Indra Jaidhauser
GSK Germany
  • Vortrag Phase 3, open-label, randomized, controlled study to evaluate immune response, safety and reactogenicity of the RSVPreF3 OA vaccine when coadministered with FLU-QIV-HD vaccine in adults aged ≥65 years Speaker
    Datum: 15.04.2024 , Zeit: 11:00 | Thema: Infektiologie
    Details
  • Vortrag Immunogenicity and safety of a second dose of the respiratory syncytial virus (RSV) prefusion F protein vaccine (RSVPreF3 OA), 12 months after the first dose in adults ≥60 years Speaker
    Datum: 15.04.2024 , Zeit: 11:37 | Thema: Infektiologie
    Details